Cargando…
Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
Colon cancer is the second leading cause of cancer-related mortality worldwide, and the prognosis of advanced colon cancer has remained poor in recent years. Galectin-9 (Gal-9) is a tandem-repeat type galectin that has recently been shown to exert antiproliferative effects on various types of cancer...
Autores principales: | Morishita, Asahiro, Nomura, Kei, Tani, Joji, Fujita, Koji, Iwama, Hisakazu, Takuma, Kei, Nakahara, Mai, Tadokoro, Tomoko, Oura, Kyoko, Chiyo, Taiga, Fujihara, Shintaro, Niki, Toshiro, Hirashima, Mitsuomi, Nishiyama, Akira, Himoto, Takashi, Masaki, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072828/ https://www.ncbi.nlm.nih.gov/pubmed/33907832 http://dx.doi.org/10.3892/or.2021.8056 |
Ejemplares similares
-
Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017) -
Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017) -
Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
por: Chiyo, Taiga, et al.
Publicado: (2019) -
Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
por: Nakahara, Mai, et al.
Publicado: (2022) -
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
por: Takuma, Kei, et al.
Publicado: (2022)